Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: Synbiotics and Low Grade Inflammation in Obese Subjects [NA]
Clinical trial update exploring synbiotics and low-grade inflammation in obese subjects with unclear status.
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: Interleukin-1 Receptor Antagonist and Insulin Sensitivity [Phase 2]
A Phase 2 clinical trial investigates the effect of an interleukin-1 receptor antagonist on insulin sensitivity in adults with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2010-12-16Clinical Trial Update: The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study [NA]
The randomized trial of the TANTALUS II System for treating type 2 diabetes was terminated. The update does not report trial results.
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes [Phase 1]
A Phase 1 clinical trial evaluating pico-tesla magnetic fields as an adjunctive treatment for Type 2 diabetes mellitus has been completed. T…
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide [Phase 3]
A Phase 3 trial comparing two basal insulins in adults with Type 2 diabetes taking oral diabetes medicines and exenatide; results were poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes [Phase 3]
Phase 3 study evaluating the combination of insulin detemir and sitagliptin for blood glucose control in adults with Type 2 diabetes; result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents [Phase 3]
A Phase 3 trial (REASSURE) evaluated the effect of rimonabant on HbA1c in overweight or obese adults with type 2 diabetes not adequately con…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors [Phase 3]
A Phase 3 trial evaluating the impact of rimonabant on regression of asymptomatic cardiovascular damage was terminated.
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: Observational Study in Japanese Type 2 Diabetes Patients
An observational study in Japanese patients with Type 2 diabetes has completed. The sponsor is Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2010-12-09Clinical Trial Update: To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients [Phase 1]
An update on a Phase 1 pharmacokinetics study of AZD1656 and its metabolite in patients with Type 2 Diabetes Mellitus. The trial status indi…
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea [Phase 3]
A Phase 3 clinical trial update for patients with Type 2 diabetes mellitus who have insufficient glycemic control on metformin alone or metf…
-
CLINICAL_TRIALS trial_result · 2010-12-08Clinical Trial Update: Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs [Phase 4]
A Phase 4 trial comparing repaglinide plus metformin versus repaglinide alone in patients with Type 2 diabetes who had not previously used o…
-
CLINICAL_TRIALS research · 2010-12-07Clinical Trial Update: The Effect of Oral Hygiene and Full Mouth Scaling on Metabolic Control in Patients With Type II Diabetes [Phase 1]
A Phase 1 clinical trial update evaluating whether improved oral hygiene and full mouth scaling affect metabolic control in patients with Ty…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients [Phase 1]
A Phase 1 single ascending dose study in healthy male volunteers and Type 2 diabetes mellitus patients was terminated.
-
FDA approval · 2010-12-06FDA Approved: RIOMET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for RIOMET (metformin hydrochloride) from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated whether adding Gynostemma pentaphyllum tea to ongoing sulfonylurea therapy improves glycemic control i…
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients [Phase 1, Phase 2]
Completed Phase 1 and Phase 2 clinical trials evaluating the anti-diabetic effects of Gynostemma pentaphyllum tea in patients with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Effect of Gynostemma Pentaphyllum Tea in Insulin Sensitivity in Type 2 Diabetic Patients [Phase 1, Phase 2]
A completed Phase 1/2 study assessed whether Gynostemma pentaphyllum tea improves insulin sensitivity in people with Type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes [Phase 1]
Phase 1 randomized, double-blind, placebo-controlled, four-way crossover study assessing safety, tolerability, and pharmacokinetics of CM3.1…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin [Phase 1]
A Phase 1 study evaluating the safety and tolerability of AZD1656 in type 2 diabetes patients on insulin has completed. The trial was sponso…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes [Phase 1]
This Phase 1 trial update reports on safety, tolerability, and effects on plasma glucose after multiple ascending oral doses of AZD1656 in i…
-
CLINICAL_TRIALS trial_result · 2010-12-02Clinical Trial Update: ¡Si, Yo Puedo Control Mi Diabetes!: A Diabetes Self-management Education Program for Hispanic/Latinos [EARLY_Phase 1]
An early-phase 1 clinical trial of a diabetes self-management education program for Hispanic/Latino individuals with Type 2 diabetes has com…
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Type 2 Diabetes Mellitus Collaborative Genetic Study on Non-aboriginal Taiwanese
A clinical trial update describes a collaborative genetic study on Type 2 Diabetes Mellitus conducted in non-aboriginal Taiwanese.
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients [Phase 4]
A Phase 4 trial reports that glimepiride demonstrated superior efficacy to sitagliptin in treatment-naïve adults with Type 2 diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial indicates that chronic reduction of fasting glycaemia with insulin glargine improves first- and second-phase insulin secreti…